Related Experiment Video

Updated: Apr 11, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

693

Biomarkers in Paediatric Cystic Fibrosis Lung Disease

Kathryn A Ramsey1, André Schultz2, Stephen M Stick2

  • 1Telethon Kids Institute, University of Western Australia, Australia; Cystic Fibrosis/Pulmonary Research and Treatment Center, University of North Carolina at Chapel Hill, North Carolina, USA.

Paediatric Respiratory Reviews
|June 9, 2015
PubMed

Insights

Biomarkers are crucial for diagnosing cystic fibrosis and assessing lung disease severity. Developing effective biomarkers, especially for infants, can improve disease management and therapy development.

Area of Science:

  • Biochemistry
  • Pulmonology
  • Medical Diagnostics

Background:

  • Biomarkers are essential for cystic fibrosis (CF) diagnosis and monitoring lung disease.
  • Current CF transmembrane regulator function tests have limitations.
  • Effective biomarkers can guide disease management and therapeutic development.

Purpose of the Study:

  • To review the role of biomarkers in cystic fibrosis diagnosis and lung disease assessment.
  • To highlight the potential of inflammation and infection biomarkers in CF management.
  • To address challenges in developing biomarkers for pediatric CF patients.

Main Methods:

  • Literature review of existing biomarkers for cystic fibrosis transmembrane regulator function.
  • Analysis of biomarkers for lung disease severity, including inflammation and infection.
  • Discussion of challenges in pediatric sample acquisition for biomarker development.

Main Results:

  • Biomarkers are used to measure CF transmembrane regulator function for diagnosis.
  • Biomarkers assess lung disease severity, such as inflammation and infection.
  • Challenges exist in developing pediatric biomarkers for early CF detection.

Conclusions:

  • Effective biomarkers aid CF diagnosis, monitoring, and therapy development.
  • Biomarkers for inflammation and infection can enhance CF patient management.
  • Overcoming pediatric sample challenges is key for early CF intervention.

Keywords:
BiomarkersCystic fibrosisPaediatricsPulmonary.

More Related Videos

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections06:57

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections

Published on: May 8, 2017

9.7K
Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome07:38

Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome

Published on: August 3, 2021

2.9K

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
636
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.4K